NCT03452241

Brief Summary

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
480

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 2, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

April 14, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2018

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2020

Completed
Last Updated

March 23, 2020

Status Verified

March 1, 2020

Enrollment Period

3 months

First QC Date

January 19, 2018

Last Update Submit

March 19, 2020

Conditions

Substance Use

Keywords

Screening, Brief Intervention, and Referral to TreatmentSubstance Use

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in risk behaviors at 1 and 3 month

    Risk Behaviors will be measured by ASSIST questionnaire.

    baseline, 1 and 3 month

Secondary Outcomes (6)

  • Knowledge related to Substance Use measured by Knowledge related to Addiction questionnaire

    baseline, 1 and 3 month

  • Motivation measured by Pre-treatment Readiness Scale

    baseline, 1 and 3 month

  • Depression measured by Self-Rating Depression Scale (SDS)

    baseline, 1 and 3 month

  • Anxiety measured by Self-Rating Anxiety Scale (SAS).

    baseline, 1 and 3 month

  • Self-esteem measured by Self-esteem questionnaire

    baseline, 1 and 3 month

  • +1 more secondary outcomes

Study Arms (3)

Intervention Group

EXPERIMENTAL

The medical staffs who received the training will use the manual of brief intervention to deliver it and other materials about the harm of substance use.

Other: Intervention Group

Control Group

OTHER

The participants only receive the materials about the harm of substance use

Other: Control Group

Intervention Group 1

EXPERIMENTAL

The medical staffs who received the training will use the manual of brief intervention twice to deliver it and other materials about the harm of substance use.

Other: Intervention Group

Interventions

Intervention GroupOTHER

The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.BI refers to a standard 15-30 minute intervention that includes a series of standard models that stimulate knowledge, motivation and behavior that reduce substance abuse.the harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.

Intervention GroupIntervention Group 1
Control GroupOTHER

The participants only receive the materials about the harm of substance use.the harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.

Control Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18-75 years;
  • the patient to the community medical institutions;
  • ASSIST score is in 12-27, in a moderate risk;
  • voluntary to participate;
  • to agree to complete baseline interviews and follow-up studies

You may not qualify if:

  • unable to complete the questionnaire;
  • serious physical illness, action inconvenience.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henan Provincical Peoples Hospital

Henan, China

Location

Related Publications (1)

  • Fu R, Yuan C, Sun W, Wang W, Zhang L, Zhai J, Guan Q, Wu X, Long J, Zhao M, Du J. Effectiveness of E-SBIRT intervention in community healthcare institution in China: study proposal for a randomised controlled trial. Gen Psychiatr. 2021 Sep 24;34(5):e100486. doi: 10.1136/gpsych-2021-100486. eCollection 2021.

    PMID: 34651102DERIVED

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Jiang Du, M.D

    Study Principal Investigator Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 19, 2018

First Posted

March 2, 2018

Study Start

April 14, 2018

Primary Completion

July 10, 2018

Study Completion

March 10, 2020

Last Updated

March 23, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)